Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children

Obesity, Childhood Clinical Trial

Official title:

The Effect of Lactoferrin Versus Iron Supplement in Treating Iron Deficiency Anemia and Helping Weight Loss in Obese School Age Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04014855
• Other study ID #: 271182
• Status: Completed
• Phase: Phase 4
• Start date: October 1, 2018
• Est. completion date: July 1, 2019

Study information

• Verified date: July 2019
• Source: Ain Shams University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The effect of lactoferrin versus iron supplement in treating iron deficiency anemia and helping weight loss in obese school age children

Description:

Comparing iron versus lactoferrin as regard iron defiency anemia and weight loss in obese children

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: July 1, 2019
• Est. primary completion date: July 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Years to 12 Years

Eligibility

Inclusion Criteria:

• 1. children age will be between 6 -12 years old. 2. Presence of iron deficiency anemia, it will be diagnosed by

• CBC >> Hemoglobin level concentration below 11.5 g/dl.

• level of serum iron is below 30 µmol/l,

• level of ferritin is below 15 µg/dl

• Total iron binding capacity is more 480 µg/dlL. 3. children should be stable and free from chronic disease. 4. Body Mass index (BMI) should be =the 95th percentile for children and teens of the same age and sex.

5. there is not history of iron supplements in the 3 months before treatment.

Exclusion Criteria:

1. Father/mother refuses to participate in the study.

2. Hospitalized patient.

3. Non-anemic patient.

4. Patients receiving iron supplements 3 months before enrollment.

5. Patients with chronic diseases.

6. personal or family history of allergy to cow's milk or infant formula, eczema, moderate-to-severe allergic rhinitis or asthma, or milk intolerance.

7. severe anemia as Hemoglobin level concentration below 7 g/dl.

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Obesity, Childhood
• Pediatric Obesity
• Weight Loss

Intervention

Drug:
• Iron Supplement
in iron deficiency anemia

Locations

Country	Name	City	State
Egypt	Marian Girgis Rizk Abdelsayed	Cairo	Non-US/Non-Canadian

Sponsors (1)

Lead Sponsor	Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	iron deficiency anemia	CBC and iron profile	3 months
Secondary	weight	Weight and body copmositiin	3 months